Search Results for: log in
Press Release
Buffalo Bills and OPKO Health’s BioReference Laboratories Initiate the First Large Scale, Mandatory COVID-19 Fan Testing Program
Dec
The Bills leverage testing capabilities from NFL testing provider, BioReference, to initiate fan testing program ORCHARD PARK, N.Y., December 31, 2020 – Buffalo Bills, 2020 AFC East Division Champions, and BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced they will be performing fan testing for the AFC Divisional Wild Card playoff game at […]
Press Release
Auth0 and BioReference Laboratories Answer Patient Demand for Secure, Direct Access to Test Results
Dec
Leading laboratory testing provider seamlessly handles 25x volume increase in patient portal users during COVID-19 with Auth0 BELLEVUE, Wash., Dec. 10, 2020 (GLOBE NEWSWIRE) — Auth0, the identity platform for application teams, today announced that it is providing BioReference Laboratories, Inc., an OPKO Health company and a leading provider of laboratory testing services in the U.S., with […]
Press Release
OPKO Health’s BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test
Oct
New offering identifies COVID-19 and Influenza infections with a single sample ELMWOOD PARK, N.J., October 20, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), is now accepting specimens for a new multiplex COVID-19 and influenza test for use by healthcare providers, clinics and health systems throughout the United States, to aid in the […]
Press Release
OPKO Health’s BioReference Laboratories Launches COVID-19 Testing Program for New York City Schools
Oct
Through New York City, BioReference will be testing students, teachers and staff in nearly 1,000 NYC public schools ELMWOOD PARK, N.J., October 9, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the beginning of its COVID-19 testing program for New York City schools throughout the 2020-2021 school year to help ensure a safer school […]
Oct
Every October, we are surrounded by a sea of pink to inspire hope and raise awareness of breast cancer. The month is dedicated to educating the public about breast cancer early detection, causes, prevention, treatment, support services and more. According to the American Cancer Society, breast cancer is the second most common cancer in American […]
Wall Street Journal BioReference Labs shut down temporarily in July in a controversial move that helped it win new business and prepare for the coming flu season Technicians processed incoming Covid-19 tests at BioReference Laboratories in Elmwood Park, N.J. ELMWOOD PARK, N.J.—In early July, as coronavirus surged across the U.S., one of the nation’s biggest laboratories involved […]
Press Release
OPKO Health’s BioReference Laboratories Announces New York City Schools COVID-19 Testing Program
Sep
The COVID-19 testing program will test principals, teachers and staff in preparation for a safer back-to-school environment ELMWOOD PARK, N.J., September 2, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today began testing New York City principals, teachers and other staff for COVID-19, across the five boroughs, in preparation for a safer back-to-school environment. Through a […]
Press Release
OPKO Health’s BioReference Laboratories Launches Best-in-Class Next-Generation Sequencing (NGS) Assay
Sep
ELMWOOD PARK, N.J., September 2, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), along with its specialty oncology division, GenPath, today announced the launch of OnkoSight AdvancedTM, a next-generation sequencing (NGS) assay that enables revolutionary deoxyribonucleic acid (DNA) mutational profiling of tumor samples. OnkoSight AdvancedNGS testing provides targeted gene content that is aligned with the latest […]
ELMWOOD PARK, N.J., August 18, 2020 – BioReference Laboratories Inc., an OPKO Health Company, is pleased to announce it is now in-network with all Blue Cross and Blue Shield of Texas (BCBSTX) products, including its Health Maintenance Organization (HMO) and Medicaid lines of business. The contract includes BioReference’s subsidiary GeneDx, Inc., a full service genetics […]
